FBLN2 and neoplasm: However, the reason for this dual role in cancer is again believed to be due, similar to fibulin-1, to other factors such as posttranslational modifications, interactions with other components of the ECM, fibulin-2 site of expression within the cancerous tissue or even the clinical grade or stage of the tumor (70, 71).